| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 05/23/2007 | EP1326993B1 Production of alpha-hydroxy-carboxylic acids using a coupled enzyme system |
| 05/23/2007 | EP1181014B1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD |
| 05/23/2007 | EP1097141B1 Imidazole derivatives with biphenylsulfonyl substitution, method for preparing them and their use as a drug or diagnostic agent |
| 05/22/2007 | US7220914 1-methyl-3-(4-sulfoxybutyl)methylimidazolium zwitterion for photovoltaic cell charge carrier layers; increased viscosity prevents the undesired flow of the charge carrier layer to outside of the photovoltaic cell |
| 05/22/2007 | US7220867 Dissolving with crystal growth inihibitos; drying |
| 05/22/2007 | US7220866 Useful in the treatment of diseases or conditions susceptible to adrenergic regulation controlled by alpha-2 adrenergic receptors |
| 05/22/2007 | US7220770 preferably selectively inhibit cyclooxygenase-2 over cyclooxygenase-1; arthritis treament |
| 05/22/2007 | US7220745 Viricides; therapy for hepatitis virus infections |
| 05/22/2007 | CA2473422C Preparation of 5-chlorimidazoles |
| 05/22/2007 | CA2368347C Glucokinase activators |
| 05/22/2007 | CA2276694C New fatty acid derivatives |
| 05/22/2007 | CA2157146C Heterocyclyl-benzoylguanidines |
| 05/18/2007 | WO2007056469A2 Certain chemical entities, compositions, and methods |
| 05/18/2007 | WO2007055392A1 Ionic compound |
| 05/18/2007 | WO2007055187A1 Metal complex compounds and organic electroluminescent devices made by using the same |
| 05/18/2007 | WO2007031833A3 Novel series of imidazolyl substituted steroidal and indan-1-one derivatives |
| 05/18/2007 | WO2007029036A3 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 05/18/2007 | WO2007006387A3 Onium-alkylsulfonate production method |
| 05/18/2007 | WO2006081807A3 Method for the production of losartan |
| 05/17/2007 | US20070112061 Heat- or singlet oxygen-generating agents and cancer treatment compositions comprising organic peroxide or chemiluminescent compound |
| 05/17/2007 | US20070112009 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them |
| 05/17/2007 | US20070112002 1-[2-(4,4-dimethylcyclohexyl)-5-methoxyphenyl]-4-pentylpiperazine; excellent cell adhesion inhibitory action or cell infiltration inhibitory action; inflammatory diseases and autoimmune diseases such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, rheumatoid arthritis, psoriasis, asthma |
| 05/17/2007 | US20070111982 Calcitonin Gene-Related Peptide, CGRP; treatment of migraine and cluster headache; 2,5-dioxo-3',4'-dihydro-spiro(imidazolidine-4,2'(1'H)-naphthalene)-6'-carboxamides |
| 05/16/2007 | EP1785417A2 Novel non-psychotropic cannabinoids |
| 05/16/2007 | EP1785134A2 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 05/16/2007 | EP1784380A1 Method for high-purity quaternary ammonium compounds |
| 05/16/2007 | CN1964957A Anionic-sweetener-based ionic liquids and methods of use thereof |
| 05/16/2007 | CN1964949A Phenylnaphthylimidazoles for use on copper surfaces during soldering |
| 05/16/2007 | CN1964948A Therapeutic agents |
| 05/16/2007 | CN1962641A Metalloproteinase inhibitors |
| 05/16/2007 | CN1962596A Ketone compounds and compositions for cholesterol management and related uses |
| 05/16/2007 | CN1315823C New method for synthesizing Ramosetron Hydrochloride |
| 05/16/2007 | CN1315386C Fungicidal active compound mixture |
| 05/15/2007 | USRE39634 treatment of neuropathic pain; elevate levels of anandamide or other endogenous cannabinoids to increase the nociceptive threshold |
| 05/15/2007 | US7217740 Diarylsulfones as 5-HT2A antagonists |
| 05/15/2007 | US7217718 Administering an immunosuppressant; therapy for autoimmune disease |
| 05/15/2007 | US7217706 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence |
| 05/15/2007 | US7217704 LPA receptor agonists and antagonists and methods of use |
| 05/15/2007 | CA2155275C Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds |
| 05/10/2007 | WO2007052843A1 Heterocyclic amide compound and use thereof |
| 05/10/2007 | WO2007052073A2 Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors |
| 05/10/2007 | WO2007025709A3 Organic compounds |
| 05/10/2007 | WO2007002701A3 Anti-inflammatory aryl nitrile compounds |
| 05/10/2007 | WO2006050265A3 Ceramides and apoptosis-signaling ligand |
| 05/10/2007 | WO2006002873A3 1 , 4 -bis (carboxymethyl) -6- ' bis ( carboxymethyl) amino ! -6 -methyl- perhydro-1 , 4 diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri ) |
| 05/10/2007 | US20070106077 Synthesis of substituted heterocyclic compounds |
| 05/10/2007 | US20070105929 2, 4, 5 - Trisubstituted Imidazoles And Their Use As Anti-Microbial Agents |
| 05/10/2007 | US20070105860 Biphenylcarboxylic Amide Derivatives as p38 Kinase Inhibitors |
| 05/10/2007 | US20070105859 4-Phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (mek) inhibitors |
| 05/10/2007 | US20070105858 Retinoic acid mimetic anilides |
| 05/10/2007 | US20070102674 Acid-base mixture and ion conductor comprising the same |
| 05/10/2007 | CA2627423A1 Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors |
| 05/09/2007 | EP1781638A2 Imidazolo-related compounds, compositions and methods for their use |
| 05/09/2007 | EP1781630A1 Novel piperidine derivative for the treatment of depression |
| 05/09/2007 | EP1781620A1 Novel beta agonists, method for producing the same and their use as drugs |
| 05/09/2007 | EP1781596A1 Amino acid derived prodrugs of propofol compositions and uses thereof |
| 05/09/2007 | EP1781595A1 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity |
| 05/09/2007 | EP1781299A1 Anti-inflammatory agents |
| 05/09/2007 | EP1268441B1 An intermediate and process for its synthesis |
| 05/09/2007 | EP1029073B1 Method and agent for determining deaminase activity |
| 05/09/2007 | CN1958575A Method for extracting polysaccharide and allantoin from Chinese yam |
| 05/09/2007 | CN1958574A Method for preparing ion liquor |
| 05/09/2007 | CN1958569A Improved technique for preparing hydantoin from glycine, sodium hydroxide, and urea |
| 05/08/2007 | US7214715 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques |
| 05/08/2007 | US7214698 Beta-agonists, processes for preparing them and their use as pharmaceutical compositions |
| 05/08/2007 | CA2331870C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 05/08/2007 | CA2325741C Urea derivatives having tnf- .alpha. production inhibitory effects |
| 05/03/2007 | WO2007049121A1 Crystal form of sodium; (3r,5r)-7-[4-benzylcarbamoyl-2-(4-fluorophenyl)-5-isopropyl-imidazol-1-yl]-3,5-dihydroxy-heptanoate |
| 05/03/2007 | WO2007048840A1 Novel beta-agonists, process for their preparation and their use as medicaments |
| 05/03/2007 | WO2007048771A1 Arylurea derivatives as modulators of chemokine receptor activity |
| 05/03/2007 | WO2007022947A3 5-ring heteroaromatic compounds and their use as binding partners for 5-ht5 receptors |
| 05/03/2007 | US20070099977 Conjugated psychotropic drugs and uses thereof |
| 05/03/2007 | US20070099975 Imidazole derivatives modulating the sodium channels |
| 05/03/2007 | US20070099952 Hif-1 inhibitors |
| 05/03/2007 | US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/03/2007 | US20070099909 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor |
| 05/03/2007 | US20070099892 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging |
| 05/03/2007 | US20070099871 Bioreductively-activated prodrugs |
| 05/03/2007 | DE102005052101A1 Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New beta-agonists, to processes for their preparation and their use as medicaments |
| 05/03/2007 | CA2627477A1 Novel beta-agonists, process for their preparation and their use as medicaments |
| 05/03/2007 | CA2626324A1 Arylurea derivatives as modulators of chemokine receptor activity |
| 05/02/2007 | EP1780197A1 5-substituted-2-phenylamino-benzamide as mek inhibitor |
| 05/02/2007 | EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands |
| 05/02/2007 | EP1778646A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 05/02/2007 | EP1778645A2 Process for producing n-halogenated organic compounds |
| 05/02/2007 | EP1778644A2 Method of coloring with capped diazotized compound and coupling component |
| 05/02/2007 | EP1778618A2 Synthesis of triethylenetetramines |
| 05/02/2007 | EP1658285B1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 05/02/2007 | CN1956980A Mercaptoimidazoles as CCR2 receptor antagonists |
| 05/02/2007 | CN1956976A Mercaptoimidazoles as CCR2 receptor antagonists |
| 05/02/2007 | CN1956965A Tetrasubstituted imidazole derivatives as cannabinoid cb1 receptor modulators with a high CB1/CB2 receptor subtype selectivity |
| 05/02/2007 | CN1955164A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/02/2007 | CN1313472C Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such |
| 05/02/2007 | CN1313448C Metalloproteinase inhibitors |
| 05/01/2007 | USRE39606 Synthetic libraries of random oligomers, each member comprising an oligomer linked to a microchip encoded with information identifying structure of oligomer, for drug screening |
| 05/01/2007 | US7211680 (5Z,7E,22E)-(1S,3R,24R)-25-phenyl-26,27-cyclo-9,10-secocholesta-5,7,10(19),22-tetraene-1,3,24-triol; treating hyperprolifierative diseases of the skin, tumor diseases and precancerous stages, auto-immune diseases, rejection reactions in the case of autologous, allogenic or xenogenic transplants, AIDS |
| 05/01/2007 | US7211595 Substituted imidazoles and thiazoles |
| 05/01/2007 | US7211590 Such as 2-(nitrooxy)ethyl-2-(((3-methyl-4-(2,2,2-trifluoro-ethoxy)-2 -pyridyl)methyl)sulfinyl)benzimidazolecarboxylate; kits; for treating gastrointestinal disorders/ulcers |
| 05/01/2007 | CA2386492C Process for the production of n,n-carbonyl diimidazole |
| 05/01/2007 | CA2227205C Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles |